MALARIA

Affordable, Live-Saving Treatments

At Qcil, we believe that no life should be lost – especially not to a treatable disease. In 2009, Qcil introduced a fixed dose artemisinin-based combination, composed of two active ingredients: artemether (20 mg) and lumefantrine (120 mg).

This treatment, recommended for uncomplicated Malaria, was made readily available and affordable, and has saved many lives.

For product sales, please contact us at sales@qcil.com or visit our Qcare app: https://qcare.qcil.com/
The products shown should not be consumed based on information provided by Qcil. Please visit your healthcare practitioner for medical advice.